Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 146 No. 2728 (2016)

High blood pressure: prevalence and adherence to guidelines in a population-based cohort

  • Diana Walther
  • Ivan Curjuric
  • Julia Dratva
  • Emmanuel Schaffner
  • Carlos Quinto
  • Thierry Rochat
  • Jean-Michel Gaspoz
  • Luc Burdet
  • Pierre-Olivier Bridevaux
  • Marco Pons
  • Margaret W. Gerbase
  • Christian Schindler
  • Nicole Probst-Hensch
DOI
https://doi.org/10.4414/smw.2016.14323
Cite this as:
Swiss Med Wkly. 2016;146:w14323
Published
03.07.2016

Summary

QUESTIONS UNDER STUDY: High blood pressure, the single leading health risk factor worldwide, contributes greatly to morbidity and mortality. This study aimed to add to the understanding of diagnosed and undiagnosed high blood pressure in Switzerland and to evaluate adherence to hypertension guidelines.

METHODS: Included were 3962 participants from the first (2001–2003) and second (2010–2011) follow-ups of the population-based Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults. High blood pressure was defined as blood pressure ≥140/90 mm Hg and the prevalence of doctor-diagnosed hypertension was based on questionnaire information.

RESULTS: High blood pressure was found in 34.9% of subjects, 49.1% of whom were unaware of this condition; 30.0% had doctor-diagnosed hypertension and, although 82.1% of these received drug treatments, in only 40.8% was blood pressure controlled (<140/90 mm Hg). Substantial first-line beta-blocker use and nonadherence to comorbidity-specific prescription guidelines were observed and remained mostly unexplained. Age-adjusted rates of unawareness and uncontrolled hypertension were more than 20% higher than in the USA.

CONCLUSIONS: There is room for improvement in managing hypertension in Switzerland. Population-based observational studies are essential for identifying and evaluating unmet needs in healthcare; however, to pinpoint the underlying causes it is imperative to facilitate linkage of cohort data to medical records.

References

  1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
  2. Table of key indicators for all the Member States; WHO Global Health Expenditure Database. [Internet] WHO. 2014 – [cited 2015 Sep 16]. Available from: http://apps.who.int/nha/database/Key_Indicators/Index/en.
  3. Storni, Marco, Kaeser, Martine, Lieberherr, Renaud. Swiss Health Survey 2012 Overview. Neuchâtel: Federal Statistical Office (CH); 2013 Feb. 31p.
  4. GBD Compare, IHME. (n.d.). http://viz.healthmetricsandevaluation.org/gbd-compare/ (accessed 2015 July 16,).
  5. Lawes CMM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006;24(3):423–30.
  6. Zellweger U, Bopp M, Holzer BM, Djalali S, Kaplan V. Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources. BMC Public Health. 2014;14:1157.
  7. Danon-Hersch N, Marques-Vidal P, Bovet P, Chiolero A, Paccaud F, Pécoud A, et al. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil. 2009;16(1):66–72.
  8. Guessous I, Bochud M, Theler J-M, Gaspoz J-M, Pechère-Bertschi A. 1999–2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PloS One. 2012;7(6):e39877.
  9. Swiss Society of Hypertension Guidelines [Internet]. Swiss Society of Hypertension. [cited 2015 May 20]. Available from: http://www.swisshypertension.ch/guidelines.htm.
  10. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.
  11. National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [Internet]. London: Royal College of Physicians (UK); 2011 [cited 2015 Oct 8]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK83274/.
  12. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
  13. Martin BW, Ackermann-Liebrich U, Leuenberger P, Künzli N, Stutz EZ, Keller R, et al. SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz- Präventivmedizin. 1997;42(2):67–84.
  14. Panczak R, Galobardes B, Voorpostel M, Spoerri A, Zwahlen M, Egger M, et al. A Swiss neighbourhood index of socioeconomic position: development and association with mortality. J Epidemiol Community Health. 2012;66(12):1129–36.
  15. Swiss Society of Hypertension. Arterial hypertension, recommendations for doctors. Swiss Society of Hypertension (CH); 2009.
  16. Marthaler M. Risques de maladies et de mortalité liés à l’alcool Bases pour des repères de consommation d’alcool à faible risque [Internet]. Addiction Suisse; 2013 [cited 2015 Jul 6]. Available from: http://www.bag.admin.ch/themen/drogen/00039/00594/11232/index.html?lang=fr
  17. SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103–16.
  18. Brenner R, Waeber B, Allemann Y. Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE), Swiss Med. Wkly. 141 (2011) w13169.
  19. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599–606.
  20. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11–9.
  21. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007;167(2):141–7.
  22. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43(1):10–7.
  23. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.
  24. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.
  25. Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens. 2004;22(6):1221–9.
  26. Erne, P, Allemann, Y. Comments to the 2007 recommendations for the treatment of essential hypertension by the Swiss Society of Hypertension. Cardiovasc Med. 2008;11(1):26–8.
  27. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27(11):2121–58.
  28. Self TH, Wallace JL, Soberman JE. Cardioselective beta-blocker treatment of hypertension in patients with asthma: when do benefits outweigh risks? J Asthma. 2012;49(9):947–51.
  29. Erdine S, Redon J, Böhm M, Ferri C, Kolloch R, Kreutz R, et al. Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol. 2013;20(5):786–92.
  30. Redon J, Brunner HR, Ferri C, Hilgers KF, Kolloch R, van Montfrans G. Practical solutions to the challenges of uncontrolled hypertension: a white paper. J Hypertens Suppl. 2008;26(4):S1–14.

Most read articles by the same author(s)

1 2 3 > >>